AB
ATNM icon

Amalgamated Bank’s Actinium Pharmaceuticals ATNM Stock Holding History

Amalgamated Bank’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-877
Closed -$1K – 3020
2025
Q1 		$1K Hold
877
– – ﹤0.01% 2899
2024
Q4 		$1K Hold
877
– – ﹤0.01% 2941
2024
Q3 		$2K Hold
877
– – ﹤0.01% 2923
2024
Q2 		$6K Hold
877
– – ﹤0.01% 2665
2024
Q1 		$7K Sell
877
-2,731
-76% -$17.6K ﹤0.01% 2558
2023
Q4 		$18K Sell
3,608
-261
-7% -$1.34K ﹤0.01% 2694
2023
Q3 		$23K Hold
3,869
– – ﹤0.01% 2571
2023
Q2 		$29K Buy
+3,869
New +$32.9K ﹤0.01% 2541

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

Amalgamated Bank's ATNM Position: Q2 2025 in Review

Amalgamated Bank sold out of Actinium Pharmaceuticals (ATNM) in Q2 2025, closing a stake of 877 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in ATNM in Q2 2023 and held it in 8 quarters. The position peaked at $29K in Q2 2023. 63 funds tracked by Wall St. Rank hold ATNM as of Q2 2025.

  • Amalgamated Bank reported no remaining Actinium Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 877 Actinium Pharmaceuticals shares in Q2 2025, an estimated $1K.
  • Amalgamated Bank first reported a position in Actinium Pharmaceuticals in Q2 2023 and held it in 8 quarters.
  • Amalgamated Bank's Actinium Pharmaceuticals position peaked at $29K in Q2 2023.
  • 63 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.